Click Here For COVID-19 (Coronavirus) Studies

RecruitMe Clinical Trial

Screening for Eligibility to Participate in an HIV Biomedical Research Study.
A protocol to find out if people are eligible for any of the HIV prevention studies we are conducting and currently enrolling people into.
Sponsor:National Institute of Health
Enrolling:Male and Female Patients
Clinic Visits:2
Age Range:Between 18 and 60 years old
IRB Number:AAAA6427
Contact: Columbia Research Unit Screening Team: 347-770-2201 /
Additional Study Information:

Almost 40,000 people get HIV in the U.S. each year and almost all occur via sexual contact, especially male-to-male contact. The number of new infections has decreased slightly each year, however, we need other HIV prevention tools, such as developing a greatly, effective HIV vaccine, to better reduce HIV infections. An HIV vaccine is the best long-term hope for ending AIDS. We are looking for healthy, 18-60 year old and HIV-negative people to join studies we conduct. SCREENING AND EDUCATION: 1. We will ask you to complete an electronic pre-screen questionnaire ( to help us determine your eligibility. 2. If eligible at that point, we will ask you to attend a one-on-one educational visit. (compensation: $20-25) If you are still interested in joining one of our studies after reviewing the study with you, we will ask about your medical history and draw blood to further assess medical eligibility. 3. We will schedule a return visit (compensation: $20-25) to review the results of your blood tests. If eligible, we will ask you to review and sign a study consent form and we will schedule you for the first study visit.

Do You Qualify?
Are you HIV-negative?YesNo
Will you be able attend 1-2 hour visits during regular business hours (M-F, 9-5)?YesNo
Are you okay with having your blood drawn?YesNo
Magdalena Sobieszczyk, MD, MPH
You may be eligible for this study

Place Holder

Who Can I Contact?
For more information, please contact:
Columbia Research Unit Screening Team
Phone: 347-770-2201